182 related articles for article (PubMed ID: 12747532)
1. Extracorporeal LDL-cholesterol elimination in the treatment of severe familial hypercholesterolemia.
Bláha M
Acta Medica (Hradec Kralove); 2003; 46(1):3-7. PubMed ID: 12747532
[TBL] [Abstract][Full Text] [Related]
2. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal treatment of hypercholesterolaemia.
Olbricht CJ
Nephrol Dial Transplant; 1993; 8(9):814-20. PubMed ID: 8255513
[TBL] [Abstract][Full Text] [Related]
4. [A comparative and technical assessment of the HELP system (heparin extracorporeal LDL precipitation) and cascade filtration (CF) for the treatment of high plasma lipids].
Loschiavo C
G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832475
[TBL] [Abstract][Full Text] [Related]
5. [LDL-apheresis in the treatment familial hypercholesterolemia].
Bláha V; Bláha M; Lánská M; Havel E; Vyroubal P; Zadák Z; Žák P; Sobotka L
Vnitr Lek; 2014 Nov; 60(11):970-6. PubMed ID: 25600044
[TBL] [Abstract][Full Text] [Related]
6. Blood rheology after LDL apheresis using dextran sulfate cellulose absorption--a case report.
Koenig W; Ditschuneit HH; Hehr R; Grunewald RW; Ernst E; Hombach V
Angiology; 1992 Jul; 43(7):606-9. PubMed ID: 1626740
[TBL] [Abstract][Full Text] [Related]
7. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
Schuff-Werner P
Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
[TBL] [Abstract][Full Text] [Related]
8. A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy.
Ertorer ME; Guvenc B; Haydardedeoglu B; Tekinturhan F
Ther Apher Dial; 2008 Oct; 12(5):396-400. PubMed ID: 18937724
[TBL] [Abstract][Full Text] [Related]
9. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
[TBL] [Abstract][Full Text] [Related]
10. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
McGowan MP
J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
[TBL] [Abstract][Full Text] [Related]
11. [LDL apheresis in the treatment of familial hypercholesterolemia].
Coker M
Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():32-46. PubMed ID: 25693361
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
[TBL] [Abstract][Full Text] [Related]
13. LDL-apheresis: results of longterm treatment and vascular outcome.
Keller C
Atherosclerosis; 1991 Jan; 86(1):1-8. PubMed ID: 2064631
[TBL] [Abstract][Full Text] [Related]
14. [Biological efficacy of LDL apheresis in major hypercholesterolemia].
Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G
Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942
[TBL] [Abstract][Full Text] [Related]
15. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia.
Schmaldienst S; Banyai S; Stulnig TM; Heinz G; Jansen M; Hörl WH; Derfler K
Atherosclerosis; 2000 Aug; 151(2):493-9. PubMed ID: 10924726
[TBL] [Abstract][Full Text] [Related]
17. LDL apheresis in the treatment of familial hypercholesterolemia: experience of Hospital Santo António, Porto.
Palma I; Caldas AR; Palma IM; Queirós JA; Madureira A; Oliveira JC; Palma P; Correia C; Ramos MH
Rev Port Cardiol; 2015 Mar; 34(3):163-72. PubMed ID: 25737291
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.
Blaha M; Cermanova M; Blaha V; Jarolim P; Andrys C; Blazek M; Maly J; Smolej L; Zajic J; Masin V; Zimova R; Rehacek V
Atherosclerosis; 2008 Mar; 197(1):264-70. PubMed ID: 17540382
[TBL] [Abstract][Full Text] [Related]
19. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation.
Grützmacher P; Landgraf H; Esser R; Okon J; Vlachojannis J; Ehrly AM; Schoeppe W
ASAIO Trans; 1990; 36(3):M327-30. PubMed ID: 2252691
[TBL] [Abstract][Full Text] [Related]
20. The Effect of LDL-Apheresis and Rheohaemapheresis Treatment on Vitamin E.
Solichová D; Bláha M; Aufartová J; Krcmová LK; Plíšek J; Honegrová B; Kasalová E; Lánská M; Urbánek L; Sobotka L
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):105-12. PubMed ID: 26052140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
